Lindbrook Capital »

Cyteir Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Cyteir Therapeutics shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Cyteir Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyteir Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyteir Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.0k 2.0k 3.01
2023-12-31 $6.1k 2.0k 3.04
2023-09-30 $5.7k 2.0k 2.84
2023-06-30 $5.2k 2.0k 2.60
2023-03-31 $3.7k 2.0k 1.82
2022-12-31 $3.3k 2.0k 1.65
2022-09-30 $4.0k 2.0k 1.99
2022-06-30 $0 6 0.00

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Cyteir Therapeutics

BML Capital Management
Acadian Asset Management
Boston Family Office
Lindbrook Capital

View all funds holding Cyteir Therapeutics